HDAC2 is required by the physiological concentration of glucocorticoid to inhibit inflammation in cardiac fibroblasts

Canadian Journal of Physiology and Pharmacology
Hai-Ning ZhangJian-Dong Luo

Abstract

We previously suggested that endogenous glucocorticoids (GCs) may inhibit myocardial inflammation induced by lipopolysaccharide (LPS) in vivo. However, the possible cellular and molecular mechanisms were poorly understood. In this study, we investigated the role of physiological concentration of GCs in inflammation induced by LPS in cardiac fibroblasts and explored the possible mechanisms. The results showed that hydrocortisone at the dose of 127 ng/mL (equivalent to endogenous basal level of GCs) inhibited LPS (100 ng/mL)-induced productions of TNF-α and IL-1β in cardiac fibroblasts. Xanthine oxidase/xanthine (XO/X) system impaired the anti-inflammatory action of GCs through downregulating HDAC2 activity and expression. Knockdown of HDAC2 restrained the anti-inflammatory effects of physiological level of hydrocortisone, and blunted the ability of XO/X system to downregulate the inhibitory action of physiological level of hydrocortisone on cytokines. These results suggested that HDAC2 was required by the physiological concentration of GC to inhibit inflammatory response. The dysfunction of HDAC2 induced by oxidative stress might be account for GC resistance and chronic inflammatory disorders during the cardiac diseases.

References

Jun 19, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kazuhiro ItoPeter J Barnes
Nov 14, 2002·The Biochemical Journal·Annemieke J M de RuijterAndré B P van Kuilenburg
Dec 9, 2003·European Heart Journal·David J Grieve, Ajay M Shah
Mar 17, 2004·Heart·Stefan D Anker, Stephan von Haehling
Apr 16, 2004·Zeitschrift für Kardiologie·S Genth-ZotzS Blankenberg
Jul 16, 2004·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Edie C GoldsmithThomas K Borg
Sep 24, 2004·Journal of Molecular and Cellular Cardiology·Min-Sheng ChenJian-Dong Luo
Oct 1, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Fiona M MoodieIrfan Rahman
May 13, 2005·The New England Journal of Medicine·Kazuhiro ItoPeter J Barnes
Aug 23, 2005·Proceedings of the American Thoracic Society·Ian M AdcockPeter J Barnes
Oct 21, 2005·The New England Journal of Medicine·Turk Rhen, John A Cidlowski
Nov 4, 2005·Proceedings of the American Thoracic Society·Ian M Adcock, Kazuhiro Ito
Dec 29, 2005·The Journal of Experimental Medicine·Kazuhiro ItoIan M Adcock
Oct 2, 2007·Arquivos brasileiros de cardiologia·Angelo Michele de CandiaEvandro Tinoco Mesquita
Jun 2, 2009·Lancet·Peter J Barnes, Ian M Adcock
Aug 4, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Neil A TurnerKaren E Porter
Sep 5, 2009·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Robert J FreishtatEric P Hoffman
Mar 2, 2010·The Journal of Steroid Biochemistry and Molecular Biology·Peter J Barnes
Mar 23, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Carolina Rosa GiodaJader S Cruz
Mar 30, 2010·The Journal of Steroid Biochemistry and Molecular Biology·Ulrike Baschant, Jan Tuckermann
May 22, 2010·Journal of Molecular and Cellular Cardiology·Sandra B HaudekMark L Entman
Jul 14, 2010·Pharmacology & Therapeutics·Petra KleinbongardRainer Schulz
Sep 22, 2010·International Journal of Chronic Obstructive Pulmonary Disease·John A Marwick, Kian Fan Chung
Jan 5, 2011·British Journal of Pharmacology·Peter J Barnes

❮ Previous
Next ❯

Citations

Apr 25, 2019·The Journal of Endocrinology·Rui SongLubo Zhang
Feb 10, 2021·Signal Transduction and Targeted Therapy·Sha XuJian-Yuan Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here